Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:39
  • Read more about Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study

Appraising the Effects of Metabolic Traits on the Risk of Glaucoma: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:37
  • Read more about Appraising the Effects of Metabolic Traits on the Risk of Glaucoma: A Mendelian Randomization Study

Dissecting Causal Associations of Diet-Derived Circulating Antioxidants with Six Major Mental Disorders: A Mendelian Randomization Study

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:34
  • Read more about Dissecting Causal Associations of Diet-Derived Circulating Antioxidants with Six Major Mental Disorders: A Mendelian Randomization Study

Virus exposure and neurodegenerative disease risk across national biobanks

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:31
  • Read more about Virus exposure and neurodegenerative disease risk across national biobanks

Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:20
  • Read more about Epidemiologic and Genetic Associations of Endometriosis With Depression, Anxiety, and Eating Disorders

Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:17
  • Read more about Antioxidants, minerals and vitamins in relation to Crohn's disease and ulcerative colitis: A Mendelian randomization study

Circulating Copper and Liver Cancer

Submitted by Frida Mäkelä on Mon, 01/30/2023 - 15:13
  • Read more about Circulating Copper and Liver Cancer

Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population

Submitted by Mari Anneli Kaunisto on Fri, 01/27/2023 - 17:04
  • Read more about Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population

Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases

Submitted by Mari Anneli Kaunisto on Fri, 01/27/2023 - 17:02
  • Read more about Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases

Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation

Submitted by Mari Anneli Kaunisto on Fri, 01/27/2023 - 16:59
  • Read more about Inflammatory and infectious upper respiratory diseases associate with 41 genomic loci and type 2 inflammation

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 407
  • Page 408
  • Page 409
  • Page 410
  • Current page 411
  • Page 412
  • Page 413
  • Page 414
  • Page 415
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement